Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic Products.

Moore, Thomas J; Mouslim, Morgane C; Blunt, Jenna L; Alexander, G Caleb; Shermock, Kenneth M

Moore, Thomas J; Mouslim, Morgane C; Blunt, Jenna L; Alexander, G Caleb; Shermock, Kenneth M.

Afiliação

Moore TJ; Institute for Safe Medication Practices, Alexandria, Virginia.
Mouslim MC; Milken Institute School of Public Health, Department of Epidemiology, The George Washington University, Washington, DC.
Blunt JL; The Center for Drug Safety and Effectiveness and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Alexander GC; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
Shermock KM; The Center for Drug Safety and Effectiveness and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

JAMA Intern Med ; 181(1): 52-60, 2021 01 01.

Article em En | MEDLINE | ID: mdl-33031559

Assuntos

Medicamentos Biossimilares; Aprovação de Drogas; Animais; Pesquisa Comparativa da Efetividade; Avaliação Pré-Clínica de Medicamentos; Humanos; Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aprovação de Drogas / Medicamentos Biossimilares Tipo de estudo: Clinical_trials Limite: Animals / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google